CD8A and neoplasm: Taken together, our study shows that the antitumor effect of combination Ad-E and αPD-1 mAb treatment depends on the accumulation of tumor-infiltrating CD3+ T cells, NK cells, IFNγ+CD8+ T cells by gut microbiota.